venlafaxine aghl xr venlafaxine (as hydrochloride) 225 mg modified release capsule
alembic pharmaceuticals australia pty ltd - venlafaxine hydrochloride, quantity: 254.7 mg (equivalent: venlafaxine, qty 225 mg) - capsule, modified release - excipient ingredients: microcrystalline cellulose; povidone; purified talc; colloidal anhydrous silica; magnesium stearate; ethylcellulose; copovidone; carmoisine; titanium dioxide; gelatin; propylene glycol; indigo carmine; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution - venlafaxine extended release capsule is indicated for the treatment of: major depression, including prevention of relapse and recurrence where appropriate; generalised anxiety disorder; social anxiety disorder; panic disorder, including prevention of relapse.
blooms the chemist venlafaxine xr venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack
arrotex pharmaceuticals pty ltd - venlafaxine hydrochloride, quantity: 84.9 mg (equivalent: venlafaxine, qty 75 mg) - capsule, modified release - excipient ingredients: iron oxide black; colloidal anhydrous silica; ethylcellulose; iron oxide red; magnesium stearate; microcrystalline cellulose; povidone; purified talc; titanium dioxide; gelatin; copovidone; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia - blooms the chemist venlafaxine xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.
blooms the chemist venlafaxine xr venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack
arrotex pharmaceuticals pty ltd - venlafaxine hydrochloride, quantity: 169.8 mg (equivalent: venlafaxine, qty 150 mg) - capsule, modified release - excipient ingredients: gelatin; ethylcellulose; sunset yellow fcf; povidone; magnesium stearate; microcrystalline cellulose; brilliant blue fcf; copovidone; allura red ac; purified talc; colloidal anhydrous silica; titanium dioxide; propylene glycol; ethanol; isopropyl alcohol; shellac; tert-butyl alcohol; sodium hydroxide - blooms the chemist venlafaxine xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.
taro-venlafaxine xr capsule (extended release)
sun pharma canada inc - venlafaxine (venlafaxine hydrochloride) - capsule (extended release) - 37.5mg - venlafaxine (venlafaxine hydrochloride) 37.5mg - selective serotonin and norepinephrine-reuptake inhibitors
taro-venlafaxine xr capsule (extended release)
sun pharma canada inc - venlafaxine (venlafaxine hydrochloride) - capsule (extended release) - 75mg - venlafaxine (venlafaxine hydrochloride) 75mg - selective serotonin and norepinephrine-reuptake inhibitors
taro-venlafaxine xr capsule (extended release)
sun pharma canada inc - venlafaxine (venlafaxine hydrochloride) - capsule (extended release) - 150mg - venlafaxine (venlafaxine hydrochloride) 150mg - selective serotonin and norepinephrine-reuptake inhibitors
apo-desvenlafaxine mr desvenlafaxine (as benzoate) 100 mg extended release tablets blister pack
arrotex pharmaceuticals pty ltd - desvenlafaxine benzoate, quantity: 146.32 mg (equivalent: desvenlafaxine, qty 100 mg) - tablet, modified release - excipient ingredients: hypromellose; colloidal anhydrous silica; purified talc; microcrystalline cellulose; stearic acid; titanium dioxide; sunset yellow fcf aluminium lake; iron oxide red; polyvinyl alcohol; macrogol 3350 - desvenlafaxine is indicated for the treatment of major depressive disorder, including the prevention of relapse.,desvenlafaxine is not indicated for paediatric use.
apo-desvenlafaxine mr desvenlafaxine (as benzoate) 50 mg extended release tablets blister pack
arrotex pharmaceuticals pty ltd - desvenlafaxine benzoate, quantity: 73.16 mg (equivalent: desvenlafaxine, qty 50 mg) - tablet, modified release - excipient ingredients: hypromellose; colloidal anhydrous silica; purified talc; microcrystalline cellulose; stearic acid; titanium dioxide; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - desvenlafaxine is indicated for the treatment of major depressive disorder, including the prevention of relapse.,desvenlafaxine is not indicated for paediatric use.
terry white chemists venlafaxine xr venlafaxine (as hydrochloride) 150mg modified release capsule blister pack
apotex pty ltd - venlafaxine hydrochloride -
terry white chemists venlafaxine xr venlafaxine (as hydrochloride) 75mg modified release capsule blister pack
apotex pty ltd - venlafaxine hydrochloride -